Sign In
Buy MCRB
$7.17
-0.160 (-2.18%)
At Close: Jun 03, 2026
146th Kentucky Derby to Run on September 5th without Fans
08:00pm, Friday, 21'st Aug 2020
Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) announced today its decision to run the 146th Kentucky Derby on September 5, 2020 without fans. CDI issued
Benzinga's Top Upgrades, Downgrades For August 18, 2020
01:48pm, Tuesday, 18'th Aug 2020
Upgrades * Wedbush upgraded the previous rating for Best Buy Co Inc (NYSE: BBY) from Neutral to Outperform. For the first quarter, Best Buy Co had an EPS of $0.67, compared to year-ago quarter EPS o
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Walmart Earnings
12:00am, Tuesday, 18'th Aug 2020
Pre-open movers
U.S. stock futures traded slightly higher in early pre-market trade, as investors are awaiting earnings from Walmart Inc (NYSE: WMT), Advance Auto Parts, Inc. (...
Seres Therapeutics, Inc. Announces Closing of Public Offerings of 12,075,000 Shares of Common Stock
08:15pm, Monday, 17'th Aug 2020
Seres Therapeutics, Inc. today announced the closing of an underwritten public offering of 12,075,000 shares of its common stock.
Why Seres Therapeutics Stock Surged Today
10:31pm, Thursday, 13'th Aug 2020
What happened Shares of Seres Therapeutics (NASDAQ: MCRB) jumped 21% on Thursday after the biotech company announced the details of its capital raise. So what Seres will sell 10.5 million shares fo
Evogene: Hidden Gems Of Computational Predictive Biology, Part 1 Of 4 (Biomica, Microbiome Therapeutics)
08:55pm, Thursday, 13'th Aug 2020
Evogene Ltd. has developed a unique Computational Predictive Biology platform, leveraging big data and artificial intelligence to life-science products such as microbes, small molecules and genes.
Seres Therapeutics, Inc. Announces Pricing of Public Offering of 10,500,000 Shares of Common Stock
01:39am, Thursday, 13'th Aug 2020
Seres Therapeutics, Inc. today announced the pricing of an underwritten public offering of 10,500,000 shares of its common stock.
Seres Therapeutics up by 390% in a Day; This Analyst Sees More Upside in the Cards
10:38pm, Tuesday, 11'th Aug 2020
To say Seres Therapeutics (MCRB) began the week with a bang would be a severe understatement. More like an earth-shattering explosion. Shares surged by 390% in Monday’s trading after the microbiome
Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
09:48pm, Tuesday, 11'th Aug 2020
Seres Therapeutics, Inc. today announced that it is commencing an underwritten registered public offering of 8,000,000 shares of its common stock.
Seres Jumps On Data, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:MCRB)
04:22pm, Tuesday, 11'th Aug 2020
Seres Therapeutics stock jumps on positive topline data. Humanigen expands Lenzilumab study in Brazil.
Seres Therapeutics (NASDAQ:MCRB) Upgraded by ValuEngine to Buy
01:36am, Tuesday, 11'th Aug 2020
Seres Therapeutics (NASDAQ:MCRB) was upgraded by investment analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Tuesday, ValuEngine reports. Several othe
Seres Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
12:00am, Tuesday, 11'th Aug 2020
Seres Therapeutics, Inc. today announced that it is commencing an underwritten registered public offering of 8,000,000 shares of its common stock.
Chardan Capital Sticks to Its Buy Rating for Seres Therapeutics (MCRB) - Markets
08:55pm, Monday, 10'th Aug 2020
Chardan Capital analyst Gbola Amusa reiterated a Buy rating on Seres Therapeutics (MCRB – Research Report) today and set a
Juros reais negativos: como você deve investir com uma inflação acima do CDI
08:02pm, Monday, 10'th Aug 2020
Nova realidade deve levar investidor a buscar mais risco na alocação de renda fixa, ainda que reserva de emergência seja penalizada
Why Seres Therapeutics Stock Skyrocketed 350% Today
07:52pm, Monday, 10'th Aug 2020
Shares of Seres Therapeutics (NASDAQ: MCRB) soared on Monday after the biotech company announced promising results from a phase 3 study of its experimental therapy for colon infections. Seres said t
